Socionext (6526) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
13 Jun, 2025Executive summary
Net sales for 1H FY2025/3 declined 15.2% year-over-year to ¥99.2B, mainly due to the end of special demand and weak Chinese market.
Operating income dropped 16.7% to ¥15.6B, and profit attributable to owners fell 24.2% to ¥11.6B.
R&D costs rose 16.8% to ¥28.8B, reflecting investment in advanced technologies and new design wins.
The company continues its transformation strategy, focusing on high-growth areas like data centers and automotive, and expanding global R&D capabilities.
Full-year forecast for FY2025/3 remains unchanged at ¥200B net sales and ¥27B operating income, but both are expected to be about 10% below initial guidance excluding FX impact.
Financial highlights
2Q FY2025/3 net sales: ¥46.4B (down 16.5% YoY); product revenue: ¥37.7B (down 22.4% YoY); NRE revenue: ¥8.4B (up 23.5% YoY).
1H FY2025/3 product revenue: ¥79.95B (down 21.2% YoY); NRE revenue: ¥18.76B (up 23.3% YoY).
Gross margin improved to 54.4% in 1H FY2025/3 from 49.7% in FY2024/3.
Extraordinary income of ¥1.79B was recorded from the sale of the Kozoji office.
Cash and cash equivalents increased to ¥74.0B as of Sep 30, 2024.
Outlook and guidance
FY2025/3 full-year forecast: net sales ¥200B (down 9.6% YoY), operating income ¥27B (down 24.0% YoY), profit ¥19.5B (down 25.4% YoY), EPS ¥108.79.
No change to the previously announced earnings forecast, despite currency tailwinds and ongoing demand weakness in China and industrial sectors.
Product revenue to decrease due to end of special demand and weak China/industrial markets; NRE revenue to increase slightly.
OP margin expected to recover in FY2027/3 as new automotive projects enter mass production.
Latest events from Socionext
- Sales rebounded, but profits and margins remain pressured by costs and FX; guidance unchanged.6526
Q3 202630 Jan 2026 - Sales guidance raised but profit outlook cut as margins shrink amid higher costs and weak demand.6526
Q2 202631 Oct 2025 - Sharp profit and sales drop in 1Q FY26/3, but full-year guidance and recovery outlook are maintained.6526
Q1 202631 Jul 2025 - Net sales fell 14.1% but operating income and R&D investment both increased.6526
Q1 202513 Jun 2025 - Revenue and profit fell sharply, but investments and design wins support future growth.6526
Q4 20256 Jun 2025 - Net sales dropped 14.4% and the full-year outlook was cut amid weak China demand.6526
Q3 20255 Jun 2025